Arkolith/Insider Trading/OCX/Form 4

Broadwood Partners, L.P.

10% OwnerOncocyte Corp (OCX) · full profile →Form 4 · filed Apr 5, 2023
Net Buying
Open-Market Buys
$8.0M
Open-Market Sells
$0
Net Open-Market Flow
$8.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 3, 2023Buy(P)0—$050.2M
Apr 3, 2023Buy(P)26.8M$0.30$8.0M50.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-23-002420) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML